Objective: Bone morphogenetic protein (rhBMP-2) has demonstrated an increased rate of interbody fusion when placed in the intervertebral space. Owing to this advantage, rhBMP-2 is being implanted with increasing frequency in the lumbar spine. The purpose was to quantify and describe the presence of bone resorption within the vertebral body after transforaminal lumbar interbody fusion with placement of rhBMP-2 within the disc space.
T ransforaminal lumbar interbody fusion (TLIF) has gained popularity since its inception by Harms and Jeszenszky 1 in 1982. This technique developed to avoid the disadvantages associated with the posterior lumbar interbody fusion approach. The advantages of TLIF include a lower neurologic risk from a unilateral approach and minimal retraction of the nerve roots and dural sac. TLIF is a reliable method to achieve an anterior and posterior lumbar fusion. [2] [3] [4] [5] [6] [7] As approaches to the lumbar spine have expanded, so have the alternatives to iliac crest bone graft. Allograft, interbody cage devices, and osteoinductive growth factors are implemented with increasing frequency in lumbar fusion procedures. Recombinant human bone morphogenetic protein-2 (rhBMP-2) has repeatedly demonstrated the ability to produce a robust lumbar interbody fusion. 8, 9 Although interest in bone morphogenetic protein has accelerated over the past several years, its unique properties were identified over 39 years ago. 10, 11 rhBMP-2 has demonstrated significant success generating a solid lumbar fusion with an anterior interbody technique (ALIF). 8, 9, [12] [13] [14] Currently, the United States Food and Drug Administration has approved rhBMP-2 on a collegen sponge for implantation and interbody fusion from an anterior approach (ALIF). However, multiple studies have demonstrated success with the usage of rhBMP-2 for an interbody fusion from a posterior or transforaminal iapproach. 15, 16 rhBMP-2 is being applied in lumbar surgery with increasing frequency at our institution. In our practice, BMP implementation occurs in the majority of both anterior and posterior lumbar interbody fusion procedures. No study has documented any unconventional outcomes associated with this growth factor. This study was designed as a retrospective radiographic evaluation to highlight previously unreported results in TLIF surgery associated with rhBMP-2.
MATERIALS AND METHODS

Patient Population
Patients included in this study enrolled in our clinical database and had undergone a TLIF with rhBMP-2. Another inclusion criterion was a computed tomography (CT) study of the lumbar spine a minimum of 3-month postoperatively. The patient population was generated by 7 orthopaedic spine surgeons at our institution. One hundred ninety-eight patients underwent a TLIF procedure with rhBMP-2 during this time period. Our clinical database identified 26 patients who met the criteria.
Patients had undergone TLIF with rhBMP-2 between December 2002 and February 2004. Currently, the use of InFUSE Bone Graft (Medtronic Sofamor Danek, Memphis, TN) (rhBMP-2) in the invertebral disc space during a TLIF procedure is an off-label use of the product. Before surgery, all patients had an evaluation for 1-level or 2-level degenerative disc disease with or without radiculopathy. All physical examinations were correlated with anatomic pathology on CT and/or magnetic resonance imaging. All patients had failed conservative management before surgery. The 26 patients in the study had an average age of 46.0 years (range 16 to 73 y). The study population included 12 females and 14 males. CT evaluation of the lumbar spine was obtained an average of 4.4 months postoperatively (range 3 to 7 mo).
All patients followed a similar postoperative pain management and therapy protocol. No anti-inflammatory medications were prescribed at any time in the postoperative period. Therapy included early ambulation and excluded excessive trunk bending or twisting.
Procedure
The TLIF procedures were performed in a similar manner among all surgeons following the technique originally described by Harms and Jeszenszky. 1 In our study, no specifications were outlined with regard to interbody implant device or the use of autograft or allograft. All patients received InFUSE Bone Graft (Medtronic Sofamor Danek, Memphis, TN) within the interbody space. A single small, medium, or large InFUSE packet (2.8 cm 3 , 5.6 cm 3 , or 8.0 cm 3 , respectively) was implemented in each surgery. Small or medium packets were used for single level TLIF procedures and large packets for multilevel TLIF procedures. InFUSE was placed upon an absorbable sponge within and adjacent to the interbody implant. Often, InFUSE sponges would be divided and implanted for both the interbody fusion and posterolateral spinal fusion. The quantitiy or dose of rhBMP-2 was not controlled in our study. A variety of interbody fusion cages and allografts were implemented for the TLIF procedure (Table 1 ). In addition to the interbody implant, procedures incorporated local autograft bone in the interbody space. At each level, care was taken to maintain all bone graft and rhBMP-2 within the disc space. All TLIF procedures were instrumented posteriorly with a pedicle screw and rod construct bilaterally.
Radiographic Evaluation
A CT study of the lumbar spine was performed a minimum of 3 months postoperatively for each patient. A radiologist experienced with the interpretation of spinal CT was chosen to evaluate the studies. Our radiologist was blinded to all patient information. The CT scans of the lumbar spine were performed with 1 mm cut imaging and included sagittal and coronal reconstructions. This technique is an effective method of evaluation of fusion with second-generation lumbar interbody cages. 17, 18 His interpretation included a description of any bone resorbtion present in the vertebral bodies.
Osteoclasis of the vertebrae would be described as mild, moderate, or severe. Mild defects would be defined as less than 25% of the area of the interbody implant and less than 3 Â 3 mm on any CT reconstruction. Moderate defects were classified as 25% to 75% of the area of the graft and no greater than a 5 Â 5 mm defect within the vertebral body. Severe defects were greater than 75% of the area of the interbody graft or greater than 1 Â 1 cm on any CT reconstruction.
RESULTS
Twenty-six patients included in our study provided 32 lumbar levels for evaluation. CT scan demonstrated 13 levels (13/32, 41%) without evidence of progression toward fusion (absence of bridging trabecular bone in the interbody space or between facet articulations). Twelve of these levels (12/13, 92%) were noted to contain bone resorbtion in the vertebral bodies. Defects were noted in 22 lumbar levels (22/32, 69%). Eleven levels demonstrated mild osteolytic defects; 4 were classified as moderate, and 7 as severe (Fig. 1) . Severe defects were often associated with graft subsidence and loss of endplate integrity (5/7, 74%) (Fig. 2) . Mild defects (4/ 11) and moderate defects (3/4) were also associated with absence of bridging bone between facet articulations or vertebral endplates.
DISCUSSION
This is the first study to evaluate these previously unreported outcomes associated with rhBMP-2 usage. Lumbar fusion rates associated with rhBMP-2 have been reported with both ALIF and TLIF procedures to be greater than 90%. 8, 12, 13, 16 Osteoinduction and fusion have been noted to develop as early as 6 months with CT evaluation of lumbar intervertebral space with rhBMP-2. 13, 14 The relationship between fusion rate and the presence of vertebral defects was not investigated in our study. The CT scans were performed too early in the postoperative period to verify the presence or absence of fusion. In addition, selection bias undoubtedly occurred secondary to our inclusion criteria. In our practice, CT evaluation is not a routine element used early in the postoperative period for asymptomatic postoperative patients. Patients with a CT scan may have been more likely to have experienced difficulty postoperatively. However, vertebral bone resorption and loss of endplate integrity occurs with the use of rhBMP-2. Bone resorption within the vertebral body led to graft subsidence and FIGURE 1. A, B, Note bone resorbtion present and graft subsidence at the L4-5 disc space. TLIF procedure at this level was performed after an anterior/posterior fusion at the L5-S1 level. This CT scan was obtained 3 months postoperatively. One limitation of our study was the lack of surgeon standardization. Our report of the TLIF experience is the data collection of the 7 surgeons at our institution. The inclusion criteria of TLIF, rhBMP-2, and postoperative CT scan yielded a highly selective patient population. Owing to the volume of patients essential for the study, our clinical database was necessary. No standardization of the interbody implant was another limitation of the study. However, we feel the presence of bone resorbtion is not implant related but rather dependent upon the cellular response to rhBMP-2. The clinical relevance of these defects was not investigated in our study. Owing to possible patient selection biases and short-term follow-up, the relevant clinical significance of these defects could not be investigated properly. However, future evaluation of patient performance will be beneficial to determine any clinical significance these areas of bone resorption may generate.
A stable posterior or anterior spinal fusion may yield a good to excellent result for the spine patient. However, graft subsidence does occur with these defects and subsidence may be a precipitating factor associated with pseudarthrosis. To avoid this complication further studies are necessary to determine the appropriate dose of rhBMP-2 and the ideal location of interbody implants or anterior surface area support necessary to prevent subsidence in the presence of vertebral resorption. Previous studies have evaluated rhBMP-2's effectiveness in the role of ALIF procedures. 8, 9, [12] [13] [14] The large surface area of the LT cage (Medtronic Sofamor Danek, Memphis, TN) may have played a role in preventing subsidence if osteolysis occurred in the early postoperative period. Often a TLIF procedure is performed with a single cage or interbody implant. After reviewing the results of this study, our surgeons have decreased the dose of rhBMP-2 in the interbody space and focused on increasing surface contact area with the vertebral endplates. Accurate placement of the interbody cage at the periphery of the intervertebral space may minimize the loss of anterior column support even with the presence of osteolysis. A well-performed posterolateral spinal fusion will aid in the stabilization of weak anterior column support in the lumbar spine. Obviously, these occurrences are present in a very small portion of the population of patients who have undergone a TLIF procedure with rhBMP-2. Our results and attention to these technical details during surgery will need to be considered with the use of rhBMP-2 and lumbar interbody fusion. Awareness of this occurrence and careful placement of anterior interbody support may decrease the possibility of postoperative difficulty for a subset of patients.
The objective of this study was to outline previously unreported radiographic results with rhBMP-2 and provide awareness for the spinal surgeon. A goal of each TLIF procedure is to promote a successful lumbar spinal fusion. Knowledge of the possibility of osteolytic defects and technical consideration with rhBMP-2 usage is necessary for the spine surgeon. Further examination and future clinical studies are necessary to determine the clinical importance of these findings.
